Current Challenges and Potential Solutions for Targeted Drug Delivery (TDD) in Cancer Pain Management.
作者信息
Chung Matthew, Kalia Hemant, Schatman Michael E, Robinson Christopher L
机构信息
Department of Pain Medicine, Division of Anesthesia, Critical Care and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Center for Research and Innovation in Spine and Pain (C.R.I.S.P.), Rochester, NY, USA.
出版信息
J Pain Res. 2025 Jan 25;18:467-469. doi: 10.2147/JPR.S514833. eCollection 2025.
Abstract
摘要
相似文献
1
Current Challenges and Potential Solutions for Targeted Drug Delivery (TDD) in Cancer Pain Management.
J Pain Res. 2025 Jan 25;18:467-469. doi: 10.2147/JPR.S514833. eCollection 2025.
2
Assessment of Health Care Utilization and Cost of Targeted Drug Delivery and Conventional Medical Management vs Conventional Medical Management Alone for Patients With Cancer-Related Pain.
JAMA Netw Open. 2019 Apr 5;2(4):e191549. doi: 10.1001/jamanetworkopen.2019.1549.
3
Choice of spinal cord stimulation versus targeted drug delivery in the management of chronic pain: a predictive formula for outcomes.
Reg Anesth Pain Med. 2020 Jan 12. doi: 10.1136/rapm-2019-100859.
4
High Cervical Intrathecal Targeted Drug Delivery: A Case Report of Refractory Oropharyngeal Cancer Pain.
Case Rep Oncol Med. 2019 Sep 10;2019:2098921. doi: 10.1155/2019/2098921. eCollection 2019.
5
Targeted Drug Delivery for the Treatment of Abdominal Pain in Chronic Pancreatitis: A Retrospective Case Series.
Cureus. 2024 Mar 30;16(3):e57285. doi: 10.7759/cureus.57285. eCollection 2024 Mar.
6
Patient Satisfaction Following Intrathecal Targeted Drug Delivery for Benign Chronic Pain: Results of a Single-Center Survey Study.
Neuromodulation. 2020 Oct;23(7):1009-1017. doi: 10.1111/ner.13167. Epub 2020 May 6.
7
Information-Theoretic Model and Analysis of Molecular Signaling in Targeted Drug Delivery.
IEEE Trans Nanobioscience. 2020 Apr;19(2):270-284. doi: 10.1109/TNB.2020.2968567. Epub 2020 Jan 22.
8
The Choice of Spinal Cord Stimulation Versus Targeted Drug Delivery in the Management of Chronic Pain: Validation of an Outcomes Predictive Formula.
Neuromodulation. 2023 Aug;26(6):1218-1225. doi: 10.1016/j.neurom.2023.02.083. Epub 2023 Apr 14.
9
Assessment of Health Care Costs and Total Baclofen Use Associated With Targeted Drug Delivery for Spasticity.
Neuromodulation. 2023 Aug;26(6):1247-1255. doi: 10.1016/j.neurom.2023.01.017. Epub 2023 Mar 6.
10
Metallic Microneedles for Transdermal Drug Delivery: Applications, Fabrication Techniques and the Effect of Geometrical Characteristics.
Bioengineering (Basel). 2022 Dec 23;10(1):24. doi: 10.3390/bioengineering10010024.
引用本文的文献
1
Examining the Effects of Interventional Pain Management Staff Controlled Substance Agreement Education for Patients with Chronic Non-Cancer Intrathecal Drug Delivery Device Opioid Therapy: A Retrospective Review.
J Pain Res. 2025 May 26;18:2699-2706. doi: 10.2147/JPR.S521458. eCollection 2025.
本文引用的文献
1
The Polyanalgesic Consensus Conference (PACC)®: Updates on Clinical Pharmacology and Comorbidity Management in Intrathecal Drug Delivery for Cancer Pain.
Neuromodulation. 2024 Sep 20. doi: 10.1016/j.neurom.2024.08.006.
2
Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.
Ont Health Technol Assess Ser. 2024 Jan 11;24(2):1-162. eCollection 2024.
3
Education and Experience in Intrathecal Drug Delivery Systems (IDDS) During Pain Medicine Fellowships.
J Pain Res. 2023 Dec 27;16:4367-4377. doi: 10.2147/JPR.S428851. eCollection 2023.
4
Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis.
Cancers (Basel). 2023 Jan 18;15(3):591. doi: 10.3390/cancers15030591.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Assessment of Health Care Utilization and Cost of Targeted Drug Delivery and Conventional Medical Management vs Conventional Medical Management Alone for Patients With Cancer-Related Pain.
JAMA Netw Open. 2019 Apr 5;2(4):e191549. doi: 10.1001/jamanetworkopen.2019.1549.
7
Pain in cancer survivors.
J Clin Oncol. 2014 Jun 1;32(16):1739-47. doi: 10.1200/JCO.2013.52.4629. Epub 2014 May 5.
8
Adult cancer pain.
J Natl Compr Canc Netw. 2013 Aug;11(8):992-1022. doi: 10.6004/jnccn.2013.0119.
9
Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
J Clin Oncol. 2002 Oct 1;20(19):4040-9. doi: 10.1200/JCO.2002.02.118.
Zotero 插件